Responses
Basic and Translational Medicine
Basic research of cardiovascular disease
GW24-e2397 Rosuvastatin could modulate insulin signalling and inhibit atherosclerosis beyond its plasma cholesterol-lowering effect in insulin-resistant mice
Compose a Response to This Article
Other responses
No responses have been published for this article.